主链含酪氨酸的聚磷酸酯抗肿瘤药物的研究

通过含酪氨酸的聚磷酸酯与药物分子进行大分子反应，制备了含５－氟尿嘧啶或氨甲蝶呤的聚磷酸酯。所得聚磷酸酯均具有两亲性，部分聚磷酸酯在水中能形成胶束。研究了这些聚合物的体外降解和释药性能，体外抗肿瘤实验表明，有些聚磷酸酯药物具有较强的抗肿瘤活性。     

主链含酪氨酸磷酸酯药物控制释放材料的研究

采用溶液缩聚方法制备了含酪酸烷基酯的聚磷酸酯，研究了聚合物对氨甲蝶呤的体外释放性能和聚合物包裹氨甲蝶呤微胶囊的制备方法及其释药性能。     

聚磷酸酯—聚氨酯药物释放材料的合成

报道了一类新型生物可降解和生物相容性药物释放材料聚磷酸酯－聚氨酯的合成和表征，研究了这类聚合物的体外降解及其对牛血清白蛋白的释放性能。     

主链含酪氨酸聚磷酸酯药物控制释放材料的研究

采用溶液缩聚方法制备了含酪氨酸烷基酯的聚磷酸酯,研究了聚合物对氨甲蝶呤的体外释放性能和聚合物包裹氨甲蝶呤微胶囊的制备方法及其释药性能     

新型聚磷酸酯药物控释材料的合成

采用溶液缩聚方法，制得含酪氨酸烷基酯的聚磷酸酯，再通过大分子反应分别得到主链带正、负电荷的聚磷酸酯，研究了这三类聚磷酸酯的体外降解行为，并对它们作为蛋白质的控制释放材料的性能进行了初步评价。     

可降解磷酸酯聚合物的合成与应用研究进展

磷酸酯类聚合物在自然界中可以降解,是环境友好的化学品.其中,分子量高的聚磷酸酯近年来在医药、塑料助剂等方面有广泛应用,分子量相对较低的磷酸酯类聚合物在饲料、表面活性剂等方面很重要.按用途的不同,综述了可降解磷酸酯聚合物的合成与应用近况.     

主链含茜草双酯亚结构单元的聚磷酸酯的合成,降解及释药性能研究

通过茜草双酯与磷酰二氯的溶液缩聚合成了８种主链含茜草双酯亚结构单元的聚磷酸酯，并以元素分析、核磁共振氢谱和红外光谱确证了它们的结构。测定了它们的数均分子量。研究了其体外降解性能，并用高效液相色谱跟踪５－氟尿嘧啶从部分聚合物基质片中的释放行为。     

高分子药物研究——ⅪⅤ.含核酸碱基和氮芥的聚磷酸酯的合成及其抗肿瘤活性初步研究

本文通过缩聚反应,合成了十二种新的含5-氟尿嘧啶、尿嘧啶、胸腺嘧啶和氮芥的聚磷酸酯。部分聚合物抗动物肿瘤试验结果表明,既含氮芥又含5-氟尿嘧啶的聚磷酸酯具有较好的抗癌活性,对小鼠艾氏腹水癌的抑制率可达60％。初步研究了这类聚合物组成与抗肿瘤活性的关系。     

含氮芥和亲脂基团的聚磷酸酯的合成及其抗肿瘤活性的初步研究

本文通过3-烷氧基1,2-丙二醇与N,N'-双(2-氯乙基)二氯磷酰胺的缩合反应,制得11种新的含氮芥和亲脂基团的聚磷酸酯.用核磁、红外光谱以及元素分析确定了聚合物的结构.部分聚合物抗肿瘤初步试验结果表明.这类聚磷酸酯对小鼠肉瘤180有一定的抑制作用.在本研究中还改进了3-烷氧基-1,2-丙二醇的合成方法.     

含双疏水侧链聚磷酸酯脂质体膜材的合成

以季戊四醇二脂肪酸酯和Ｐ，Ｐ 二氯磷酸β 溴乙酯为单体，通过溶液缩聚反应合成聚磷酸酯，再经季铵化反应得到三种新的含双疏水侧链的磷脂酰胆碱型聚磷酸酯脂质体膜材．采用逆相蒸发法制备脂质体．电镜观察表明，所有聚合物都能形成脂质体，其直径为２～６μｍ．还研究了对抗肿瘤药物５ 氟脲嘧啶的包封，其包封率为３０％．     

CHEMOTHERAPEUTIC POLYMERS ⅩⅩⅢ SYNTHESIS AND ANTITUMOR ACTIVITY OF POLYPHOSPHATES CONTAINING BOTH NUCLEIC ACID BASE AND PHOSPHONOACETIC ACID ETHYL ESTER

Eight new polyphosphates containing both nucleic acid base and phosphonoacetic acid ethyl ester were synthesized by the polycondensation of P, P-dichloride of phosphonoacetic acid ethyl ester with 1, 3-dihydroxyalkyl-5-fluorouracil, 1,3-dihydroxyalkyl-uracil and 1,3-dihydroxyalkylthymine. These polyphosphates were tested against Ehrlich Ascites Carcinoma in mice. Polymer IIa and IIc exhibited excellent antitumor activity. IIc also showed lower toxicity.     

Synthesis of 4-Alkynyl-substituted 3,4-Dihydropyrimidin-2(1H)-ones

4-Alkynyl-3,4-dihydropyrimidin-2-(1H)-ones were synthesized by a one-pot reaction of propynals, ethyl acetoacetate, and urea. The yields of acetylenic dihydropyrimidinones depend significantly upon the propynal structure and catalyst type. A comparative study of the catalysts revealed an important advantage of polyphosphate ester in tetrahydrofuran in comparison with hydrochloric acid in methanol or trimethylchlorosilane in dimethylformamide, allowing the preparation of target compounds in good or moderate yields.     

Studies on quinoline derivatives and related compounds. 1. A new synthesis of 1-alkyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids

A novel preparative method for 1-alkyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids was developed. The key process is the cyclization of N-alkylanilinomethylenemalonales, which was effected successfully in the presence of polyphosphoric acid, polyphosphate ester, boron tri-fluoride or a mixture of acetic anhydride and sulfuric acid. With phosphorus oxychloride, N-alkylanilinomethylenemalonates yielded 1-alkyl-4-chloro-3-carbethoxyquinolinium salts which were hydrolyzed readily to ethyl 1-alkyl-1,4-dihydro-4-oxo-3-quinolineearboxylates or their acids. By means of this novel method several new 1-alkyl-1,4-dihydro-4-oxo-3-quinolineearboxylic acids were prepared.     

含5-氟尿嘧啶生物可降解聚磷酰胺的合成及其抗肿瘤活性研究

通过L-赖氨酸(N¹-5-氟尿嘧啶)烷基酯双盐酸盐与二氯磷酸乙酯、二氯膦甲酸乙酯、二氯膦乙酸乙酯共聚,合成了三类12种侧链含5-氟尿嘧啶的聚磷酰胺。聚合物的结构经UV、IR、¹H NMR及元素分析鉴定。聚合物用微量细胞培养四氮唑实验方法(MTT法)进行了对人肝癌细胞系Bel-7402细胞的微量培养实验。     

Pyrroloindoles. 12. Synthesis of 1H, 10H-benzo[e]pyrrolo[3,2-g]indole

Cyclization of ethyl pyruvate 2,3-naphthylenehydrazone in polyphosphate ester gives 2,9-diethoxycarbonyl-1H,10H-benzo[e]pyrrolo[3,2-g]indole, which on hydrolysis and decarboxylation of the resulting acid affords the unsubtituted 1H,10H-benzo[e] pyrrolo[3,2-g]indole.For communication 11, see [1].Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 9, pp. 1222–1224, September, 1985.     

通过形成二酪氨酸酯酒石酸盐法制备D-酪氨酸的新方法

研究了在乙醇溶液中光学活性L-酒石酸拆分DL-酪氨酸乙酯时的特性, 发现溶液中同时存在着酒石酸、酪氨酸乙酯酒石酸氢盐和二酪氨酸乙酯酒石酸盐, 三者之间的平衡关系影响拆分结果, 所得酪氨酸的构型与L-酒石酸和DL-酪氨酸乙酯的投料摩尔比有关. 前者的摩尔数大于后者时为富D-酪氨酸乙酯, 小于后者时为富L-酪氨酸乙酯, 两者相当时则得到DL-酪氨酸乙酯. 进一步的研究探讨了D-酒石酸、L-酒石酸与L-酪氨酸乙酯在不同摩尔比下的成盐特性, 从而解释了酒石酸拆分酪氨酸乙酯过程中的这一特性, 说明由于二L-酪氨酸乙酯酒石酸盐和二D-酪氨酸乙酯酒石酸盐在乙醇中溶解度都很小, 因此通过酒石酸拆分酪氨酸乙酯的方法不能得到高光学纯度的D-酪氨酸. 在此基础上, 通过形成二酪氨酸甲酯酒石酸盐的方法, 在甲醇中成功地用D-酒石酸拆分制备了D-酪氨酸, 光学纯度99% ee.     

N-(5-氯-2-羟苯基)氨基酸酯的合成、表征及抑菌活性

以5-Cl水杨醛和L-苯丙氨酸、L-亮氨酸及L-甘氨酸的脂肪酸酯为原料,通过碱催化的席夫碱缩合反应,合成了6种N-（5-氯-2-羟苄基）席夫碱氨基酸酯及其还原产物N-（5-氯-2-羟苄基）氨基酸酯。 化合物的结构及组成经过IR、¹H NMR和元素分析测试技术进行了表征。 合成的席夫碱及其还原产物对革兰氏阴性菌、革兰氏阳性菌及真菌均有不同程度的抑制作用。 质量分数为0.01%的N-（5-氯-2-羟苄基）席夫碱氨基酸酯对大肠杆菌的抑菌率达90%以上,而N-（5-氯-2-羟苄基）氨基酸酯对金黄色葡萄球菌的抑菌率也在90%以上,均为强抑菌活性,其中N-（5-氯-2-羟苄基）苯丙氨酸酯的抑菌率达98%以上。     

Synthesis of chemically stabilized phosmidosine analogues and the structure--activity relationship of phosmidosine

Phosmidosine is known to have potent antitumor activity and the unique property of stopping cell growth at the G(1) phase in the cell cycle. However, this natural product having N-prolylphosphoramidate and O-methyl ester linkages on the 5'-phosphoryl residue is unstable under basic conditions and even during the chemical synthesis due to its inherent methyl transfer activity. To find stable derivatives of phosmidosine, a variety of phosmidosine analogues 1a-d replaced by longer alkyl groups in place of the methyl group on the phosphoramidate linkage were synthesized by reaction of alkyl N-(N-tritylprolyl)phosphorodiamidite derivatives 7a-d with an 8-oxoadenosine derivative 4 protected with acid-labile protecting groups. Consequently, the O-ethyl ester derivative 1b was found to be sufficiently stable in aqueous solution. When the prolyl group was replaced by other aminoacyl moieties, the reaction of N-tritylaminoacylamide derivatives 25a-d with an appropriately protected 8-oxoadenosine 5'-(ethyl phosphoramidite) derivative 9 gave better results than the above coupling reaction. A phosphoramidothioate derivative 17 and several simple compounds such as 11, 13, and 15 lacking partial structures of phosmidosine were also synthesized. The antitumor activities of these modified analogues were extensively studied to clarify the structure-activity relationship of phosmidosine. As a result, the two diastereoisomers of longer alkyl-containing phosmidosine analogues both proved to have similar antitumor activities. Replacement of l-proline with other l-amino acids or d-proline resulted in considerable decrease of the antitumor activity. The non-nucleotidic materials 13 did not show any antitumor activity, but a simple core compound of 11 exhibited weak cytotoxicity. The phosphoramidothioate derivative 17 maintained essentially a similar antitumor activity, but the efficiency decreased slightly.     

Studies on quinoline derivatives and related compounds. II. Synthesis of 5-substituted 1-ethyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

The cyclization of m-substituted anilinomethylenemalonates ( 1 ) in the presence of polyphosphate ester and some other cyclizing agents gave mixtures of the isomeric ethyl 5- ( 2 ) and 7-substituted 4-hydroxy-3-quinolinecarboxylates ( 3 ), which led to mixtures of the corresponding quinolinecarboxylic acids ( 4 and 5 ) by hydrolysis. The proportions of 4 and 5 in the mixtures were determined on the basis of their nmr spectra. Novel 5-chloro- ( 8a ), 5-methyl- ( 8b ) and 5-nitro-1-ethyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids were prepared and evaluated for antimicrobial activities. No significant activity, however, was noted.